Skip to main content
. 2021 Aug 5;9(8):959. doi: 10.3390/biomedicines9080959

Figure 2.

Figure 2

The heparin-PF4-IgG antibody complexes can activate platelets, via the FcεRI, FcεRII, FcγRII receptors and cause heparin-induced thrombocytopenia with thrombosis.